Adcock Ingram has launched a recall to SA distributors of a batch of Panado Paediatric alcohol-free grape-flavoured syrup, due to “precipitation” detected in the medicine’s active ingredient, paracetamol.
This means the product did not meet the final specifications relating to visual description.
The company’s medical director, Dr Thiruvasan Govindsamy, said both 50ml and 100ml products – with expiry dates in July 2025 and February and April 2026 – are affected.
Govindsamy told News24 the recall is specified as Class III, meaning it poses the least risk to patients.
“The recall is also Type B, meaning it is only designed to reach wholesalers, private and state hospitals, doctors, nurses, pharmacists and retail outlets,” he added.
“We do not expect patients to experience any side effects, but we are recalling it from distribution points.”
See more from MedicalBrief archives:
Global ingredients’ shortage threatens SA medicine supply, warns Adcock
UK firm recalls cough medicines from US
No toxicity traces in Benylin, says SA regulator